Comments

DECEMBER 22, 2016 – Portrait of Tabitha Wegner and her children Gage, 9 and Nevaeh, 10 at their Windsor home on December 22, 2016. Tabitha Wegner won’t see her children grow up and fall in love.

Immunotherapy offers hope to cancer patients

Three months before physicians at Medical University Hospital discharged Madelyn Graf to hospice – some of them convinced that her cancer was incurable and her death was imminent – she came home from the gym perfectly healthy except for a stomach ache. But the pain became progressively intense that afternoon, wrapping around her torso.

We’re Bullish on Wide-Moat Amgen

Amgen has its roots in providing supportive-care products to kidney disease and cancer patients, and free cash flow as a percentage of sales hovers near 40% as the company undertakes massive cost-cutting and improves manufacturing. Strong newer blockbusters like Prolia/Xgeva and future blockbuster Repatha should defend Amgen’s wide economic moat from erosion caused by biosimilar and branded competition.

Mariah Carey entertains woman living with breast cancer

Christmas arrived a week early for a smiling Larissa Podermanski when she met pop star Mariah Carey Saturday backstage at the Beacon Theater in New York City. Fast-forward to the end of a fairytale night when Podermanski , who grew up in Middletown and Middlefield, spoke to Carey , an international musical diva, during a 15-minute private interlude backstage.

Kidney Cancer Therapeutic and Drug Pipeline Review H2

PUNE, INDIA, December 23, 2016 / EINPresswire.com / — GET SAMPLE REPORT @ Summary Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer pipeline landscape. Kidney cancer also called renal cancer is a disease in which kidney cells become malignant and grows out of control, forming a tumor.

Cellceutix Wishes Shareholders Happy Holidays, Prepares for 2017 Focused on Partnerships

Cellceutix Corporation, , a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and antibiotic applications, would like to wish all Cellceutix shareholders, their families and friends a happy and healthy holiday season. In 2016, Cellceutix remained extremely transparent in keeping shareholders current on developments, including comprehensive updates via news releases and corporate presentations covering the status of clinical trials and anticipated milestones pertaining to those trials for 2017.

Report: Charleston VA employees ‘improperly’ handled appointment records

A new federal report has determined that patient appointment requests at Charleston’s Ralph H. Johnson VA Medical Center were sometimes marked “discontinued” or “completed” when it was not clear that veterans had been seen yet by outside health care providers. In one case, an elderly patient with advanced liver cancer was referred by the VA to an outside radiation oncologist in mid-2012.

Health Highlights: Dec. 20, 2016

The therapy features lasers and a drug made from deep sea bacteria, and does not cause severe side effects, BBC News reported. A clinical trial of 413 prostate cancer patients at 47 hospitals across Europe found that 49 percent had no remaining trace of cancer after undergoing the treatment.

Blog: Where is the TV camera?

With Christmas fast approaching, the inflation of charitable events has been taking over Slovakia. Yes, it’s that time of the year when I wish people noticed that children’s hospitals have more wards than the “oncology” one.

Lasers a transforma prostate treatment

The approach, tested across Europe, uses lasers and a drug made from deep sea bacteria to eliminate tumours, but without causing severe side effects. Trials on 413 men published in The Lancet Oncology showed nearly half of them had no remaining trace of cancer.

10 cancer symptoms you could be missing

If something appears unusual and doesn’t go away in a couple of weeks, get it checked out. Photo / Getty Most of us think we know the telltale signs of cancer: a lump in the breast, unexplainable tiredness, sudden weight loss… but experts are pointing to lesser known symptoms to watch out for that may lead to earlier detection of the disease.

New Ovarian Cancer Drug Wins Speedy FDA Approval

U.S. health officials have approved a new option for some women battling ovarian cancer: a drug that targets a genetic mutation seen in a subset of hard-to-treat tumors. The Food and Drug Administration cleared the drug, Rubraca, from Clovis Oncology Inc. for women in advanced stages of the disease who have already tried at least two chemotherapy drugs.

This drugmaker is taking an unprecedented approach to getting its cancer treatment approved

As researchers look for new approaches for tough-to-treat cancer, many are looking into genetics – more specifically, they’re looking at the type of genetic mutations found in cancerous tumors. One company in particular, called Loxo Oncology is building drugs that act on those mutations, so that the type of cancer someone has wouldn’t matter so much as the genetic information gleaned from sequencing the tumor.

AMP publishes joint guidelines for interpretation, reporting of sequence variants in cancer

The Association for Molecular Pathology , the premier global, non-profit molecular diagnostics professional society, today published guideline recommendations for both clinical laboratory professionals and oncologists that assess the status of next-generation sequencing -based cancer tests and establish standardized classification, annotation, interpretation, and reporting conventions for somatic sequence variants. The new guideline was developed by a Working Group comprised of representatives from major professional associations whose members provide professional testing and treatment services to cancer patients.